Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
TVGN
TVGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TVGN News
BETA Technologies Reports Disappointing Q4 Results
1d ago
Benzinga
Tevogen CEO Actively Evaluating Acquisition Opportunities
3d ago
stocktwits
Tevogen Bio Advances Generics Acquisition Strategy
4d ago
Benzinga
Marvell Technology Surges After Strong Q4 Earnings Report
4d ago
Benzinga
Tevogen Considers Acquisition of Apozel Pharmaceuticals
4d ago
stocktwits
Tevogen Enters Letter of Intent with Apozeal for Strategic Acquisition
5d ago
Newsfilter
Tevogen Approves 1-for-50 Reverse Stock Split
6d ago
seekingalpha
Tevogen Signs Letter of Intent with Global CRO
Feb 27 2026
Newsfilter
Tevogen Enters Letter of Intent with Sciometrix for Potential Acquisition
Feb 26 2026
Newsfilter
Tevogen Signs Letter of Intent with Sciometrix for Potential Acquisition
Feb 26 2026
Newsfilter
TEVOGEN BIO HOLDINGS INC - AGREEMENT MAY TRANSFORM TEVOGEN INTO A PROFITABLE HEALTHCARE BUSINESS
Feb 26 2026
moomoo
TEVOGEN ENTERS LETTER OF INTENT TO ASSESS POSSIBLE ACQUISITION OF SCIOMETRIX AND ITS DIGITAL CARE MANAGEMENT PLATFORM, CLINICUS
Feb 26 2026
moomoo
Tevogen Evaluates Potential Special Cash Dividend
Jan 30 2026
Newsfilter
Tevogen Modifies Long-Term Incentive Program to Drive Growth
Jan 29 2026
Newsfilter
Tevogen Bio Achieves Multiple Milestones in 2025, Expands Cell Therapy Pipeline
Jan 12 2026
Newsfilter
Tevogen Founder Donates 230,000 Shares to Support Education Initiatives
Dec 22 2025
Globenewswire
Show More News
